Solvay Posts Higher Profits and Sales; Rhodia to Be Consolidated from this Quarter

Solvay posted a more than seven-fold increase in third-quarter 2011 net profits compared with the same period of 2010, to €73 million on sales from continuing operations up 5%, to €1.6 billion. Recurring Ebitda (Rebitda) from continuing operations increased 13%, to €264 million. The results do not include earnings and sales of the former Rhodia, which Solvay acquired in September. Rebitda at the former Rhodia operations increased 16% year on year in the third quarter, to €273 million on sales up 23%, to €1.7 billion, Solvay says. Results...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers